Lipovir

Aciclovir, the active ingredient in Lipovir, is a nucleoside analogue antiviral presented as an unspecified strength/topical cream for topical use. It treats herpes labialis and other herpes simplex skin infections in adults.

GNH USA supplies Lipovir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Aciclovir acts on herpes simplex viruses that cause skin and mucosal lesions.

Herpes labialis: reduces the duration and severity of cold sore outbreaks. Herpes simplex skin infections: promotes healing of vesicular lesions caused by HSV‑1 or HSV‑2. Herpes simplex keratitis (topical adjunct): assists in managing ocular surface lesions when used under specialist supervision.

Aciclovir topical preparations are generally well tolerated, but local reactions can occur.

Common Side Effects: - Local irritation: mild burning or stinging at the application site. - Redness: transient erythema around the treated area. - Itching: occasional pruritus during early use.

Serious or Rare Side Effects: - Allergic contact dermatitis: rash, swelling, or blistering requiring medical attention. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis, extremely rare. - Systemic absorption leading to nephrotoxicity: reported only with extensive use over large body surface areas.

Before using Lipovir, consider the following safety measures.

Pregnancy: consult a healthcare professional; safety data are limited. Breastfeeding: discuss potential risks with a clinician. Open wounds: avoid application on extensive broken skin. Concurrent ocular use: do not apply near eyes unless directed by a specialist. Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture and direct sunlight.

Aciclovir topical may interact with other agents applied to the same area.

Major Interactions (Avoid): - Other topical antivirals: may increase local irritation. - Topical corticosteroids: can mask signs of infection and delay healing.

Moderate Interactions (Monitor Closely): - Dermatologic agents containing alcohol: may enhance burning sensation. - Occlusive dressings: can increase systemic absorption, especially on large areas. - Renal impairment: systemic exposure may rise if applied extensively; monitor renal function.